Considering that vitamin C has been utilized for a clinical trial (33), our study not only provokes clear biomarkers and molecular mechanism on the basis of TET2–KMT2D axis, but also proposes an alternative strategy for management of HCC. This evidence concerns the gene KMT2D and hepatocellular carcinoma.